CD4 and neoplasm: This example demonstrates how the specific cytokine environment within the tumor can influence the effectiveness of immune checkpoint therapy by directing CD4+ T cells away from a Th1 phenotype towards Th17 cells, which may compromise anti-cancer immunity.